# Structured Dashboard: ABRIDGE

Generated: 2025-11-05T14:33:11.501464
Source: Structured Payload (data/payloads/abridge.json)

---

## Company Overview
- **Legal Name:** Abridge
- **Founded Year:** 2019
- **Headquarters:** Pittsburgh, PA, USA
- **Website:** [abridge.com](https://www.abridge.com/)
- **Categories:** Generative AI, Healthcare Technology, Clinical Documentation, AI for Healthcare, Natural Language Processing
- **Total Raised:** $100,000,000
- **Last Disclosed Valuation:** $1,000,000,000
- **Last Round Name:** Series B
- **Last Round Date:** August 12, 2025

## Business Model and GTM
- **Products:**
  1. **Abridge Contextual Reasoning Engine:** Leading healthcare AI infrastructure, powering the most trusted billable, clinically useful, and compliant notes at the point of care.
  2. **Abridge AI Platform:** Enterprise-grade AI for clinical conversationsâ€”trusted by the largest healthcare systems, measurably improving outcomes for clinicians, nurses, and revenue cycle teams at scale.
  3. **Abridge Inside Epic:** Capture patient conversations in Haiku. Trust and verify AI note drafts in Hyperspace using Linked Evidence.
- **Pricing Model:** Not disclosed.
- **Active Products:** Not disclosed.
- **Geo Presence:** Not disclosed.

## Funding & Investor Profile
- **Funding Events:**
  1. **Funding announcement for Real Time Prior Authorization** on August 12, 2025.
  2. **Partnership with AltaMed Health Services Corporation** on April 29, 2025.
  3. **Partnership with Sharp HealthCare** on April 10, 2025.
- **Investors:** Not disclosed.

## Growth Momentum
- **Headcount Total:** Not disclosed.
- **Headcount Growth Percentage:** Not disclosed.
- **Job Openings Count:** Not disclosed.
- **Hiring Focus:** Not disclosed.

## Visibility & Market Sentiment
- **Market Sentiment:** Not disclosed.
- **Visibility:** Not disclosed.

## Risks and Challenges
- **Risks and Challenges:** Not disclosed.

## Outlook
- **Future Outlook:** Not disclosed.

## Disclosure Gaps
- Information regarding specific investor details, job openings, headcount metrics, market sentiment, risks, challenges, and future outlook is not disclosed.